2021 - Reliable identification of cardiac liability in drug discovery using automated patch clamp: Considerations and best practices for high throughput recordings of NaV 1.5

icon pl   Patchliner and   icon sp96  SyncroPatch 384i (a predecessor model of SyncroPatch 384) Physiology 2021  logo pdf   (2 MB)


For reliable identification of cardiac safety risk, compounds should be screened for effects on cardiac ion channels in addition to hERG including NaV1.5 and CaV1.2 Automated patch clamp (instruments are increasingly adopted for cardiac safety measurements but cross site and cross platform comparisons of IC50 values has identified the need for standardized
protocols for reliable pharmacology In this study, we identified different parameters that might affect IC50s of compounds on NaV1.5 peak and late currents recorded using APC.

Back to Overview

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.